Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

March 8, 2013
Galapagos regains rights to all assays and targets   Read More »
March 6, 2013
Aims to advance Quarfloxin and associated anticancer technologies   Read More »
March 6, 2013
R&D pact cover cell culture systems for stem cells   Read More »
March 1, 2013
Will apply mucoadhesive tech for needle-free administration   Read More »
February 28, 2013
To develop compounds for the treatment of lupus   Read More »
February 27, 2013
Araxes to receive upfront payment and R&D funding, eligible for royalties   Read More »
February 27, 2013
To develop dual Syk/JAK inhibitors for ophthalmic indications   Read More »
February 26, 2013
Aims to develop new antibiotics targeting Gram-negative bacteria   Read More »
February 26, 2013
Aims to commercialize six products in emerging markets   Read More »
February 25, 2013
Will combine technologies to evaluate anti-cancer drug   Read More »
February 22, 2013
Canadan pact aims to advance promising programs   Read More »
February 22, 2013
Aims to advance an immune therapeutic treatment   Read More »
February 21, 2013
To develop FISH-based test to identify high-risk CLL patients   Read More »
February 21, 2013
Aims to develop excipients to enhance solubility, bioavailability   Read More »
February 20, 2013
Aims to provide new processes for API development and manufacture   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On